A phase 1/2 of a combination of cetuximab and taxane for "triple negative" breast cancer patients. (Q54352127)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase 1/2 of a combination of cetuximab and taxane for "triple negative" breast cancer patients. |
scientific article |
Statements
A phase 1/2 of a combination of cetuximab and taxane for "triple negative" breast cancer patients. (English)
Hovav Nechushtan
Gilad Vainer
Hana Stainberg
Asher Y Salmon
Tamar Hamburger
Tamar Peretz
14 May 2014
23
4
435-438